Insight Holdings Sells Shares of Hinge Health

On June 23, 2026, LLC Insight Holdings Group sold 112,477 shares of Hinge Health, Inc. (NYSE:HNGE) in a planned transaction. The shares were sold at an average price of $70.21, totaling approximately $7.9 million. This transaction was part of a previously arranged plan.

Insider Buying and Selling at Hinge Health, Inc.

Insight Holdings Group has been active in trading Hinge Health shares. On June 23, 2026, they executed a planned sale of 112,477 shares. The following day, June 24, they conducted additional transactions involving 533,228 shares, both buying and selling, under different conditions.

Other Institutional Activity in Hinge Health

Several other institutional investors have adjusted their positions in Hinge Health. Deer Management Co. LLC opened a new position, acquiring 2,633,707 shares worth about $101.6 million. In contrast, Bit Capital GmbH reduced its holdings by 1,006,304 shares, leaving it with 2,309,797 shares valued at approximately $89.1 million. RTW Investments, LP significantly increased its stake by 1,576,500 shares, bringing its total to 1,930,000 shares valued at $74.4 million.

Hinge Health, Inc. Stock Down 19.2%

As of Thursday, shares of Hinge Health, Inc. traded near $70.38. The company, with a market cap of approximately $5.33 billion, has a forward P/E ratio of 20.6. Over the past year, the stock has ranged from a low of $30.08 to a high of $71.43. Its 50-day moving average stands at $52.90, while the 200-day moving average is $47.85. The company maintains a current ratio of 1.30 and a quick ratio of 1.04, with a debt-to-equity ratio of 2.24.

Analysts Set New Price Targets

Analysts remain optimistic about Hinge Health's prospects. On June 24, 2026, Wells Fargo maintained a 'buy' rating with a price target of $90. Other firms, including Baird and Raymond James, have also maintained their ratings, with target prices of $65 and $80, respectively. The consensus among 15 analysts is a 'buy' recommendation, with a mean target price of $79.73.

About Hinge Health

Hinge Health, Inc., headquartered in San Francisco, California, operates in the healthcare sector, specifically within health information services. The company, led by CEO Daniel A. Perez, employs 1,437 people. It focuses on using technology to deliver scalable musculoskeletal care, addressing issues like acute injury and chronic pain. Hinge Health offers personalized care through AI-powered motion tracking and proprietary wearable devices, primarily serving self-insured employers.

Bottom Line

Insight Holdings' planned sale of Hinge Health shares is a routine transaction under a trading plan. While these insider activities are closely watched, they do not necessarily indicate a change in the company's outlook. Hinge Health continues to attract interest from institutional investors and analysts, reflecting its position in the healthcare technology space.